Product Detail
Canagliflozin-d4
Canagliflozin Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Canagliflozin
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Canagliflozin-d4 Product Information
Canagliflozin-d4 is listed under Stable Isotopes. It is associated with Canagliflozin and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-10809.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Canagliflozin-d4
CAS No.
1997338-61-0
CAT No.
CS-O-10809
Molecular Formula
C24H21D4FO5S
Molecular Weight
448.5
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O[C@H]1[C@H](C2=CC(CC3=CC=C(C(C([2H])=C4[2H])=C(C([2H])=C4F)[2H])S3)=C(C)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
IUPAC Name
"(2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl-2,3,5,6-d4)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol"
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Labeled Canagliflozin; Canagliflozin Stable Isotope;Labeled Canagliflozin, intended for use as an internal standard for the quantification of Canagliflozin by GC- or LC-mass spectrometry."
Synonyms
(2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl-2,3,5,6-d4)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Application Notes
"Labeled Canagliflozin; Canagliflozin Stable Isotope;Labeled Canagliflozin, intended for use as an internal standard for the quantification of Canagliflozin by GC- or LC-mass spectrometry."
References
"Chao, E, et al,: Drug Fut,, 36, 351 (2011); Sha, S, et al,: Diab, Obes, Metab,, 13, 669 (2011); Kipnes, M,S,: Clin, Invest,, 1, 145 (2011);"